DYN position history
The shares of Dyne Therapeutics (DYN) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q2: 6,000 shares, $212K, <0.01% of portfolio, New
- 2024 Q3: 428,000 shares, $15M, 0.08% of portfolio, Add +7033.3%
- 2024 Q4: 229,121 shares, $5.4M, 0.03% of portfolio, Reduce −46.5%
- 2025 Q1: 10,000 shares, $105K, <0.01% of portfolio, Reduce −95.6%
- 2025 Q2: 10,000 shares, $95K, <0.01% of portfolio
- 2025 Q3: 20,000 shares, $253K, <0.01% of portfolio, Add +100.0%
- 2025 Q4: 10,000 shares, $196K, <0.01% of portfolio, Reduce −50.0%
- 2026 Q1: 10,000 shares, $181K, <0.01% of portfolio
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|